DetailsChartProfileRisk matrixNewsDocuments

Bellevue F.(L)-B.He.Strategy I CHF/  LU1477743030  /

Fonds
NAV6/6/2023 Chg.+0.9100 Type of yield Investment Focus Investment company
214.8800CHF +0.43% reinvestment Equity Waystone M.Co.(Lux) ▶
     
Chart for Bellevue F.(L)-B.He.Strategy I CHF
  Name   ISIN Performance Volatility Sharpe ratio
1. MEDICAL BioHealth EUR E LU1783158469 +28.49% 27.52% 0.91
2. MEDICAL BioHealth EUR IX LU1152054125 +28.38% 27.52% 0.91
3. MEDICAL BioHealth EUR I LU0294851513 +28.02% 27.52% 0.89
4. MEDICAL BioHealth EUR LU0119891520 +27.39% 27.53% 0.87
5. J.Henderson Gl.Life Sciences F.H2 IE00B8GQ0T69 +17.11% 16.02% 0.85
6. J.Henderson Gl.Life Sciences F.A2 IE00BRJG7840 +16.11% 15.80% 0.80
7. J.Henderson Gl.Life Sciences F.H2 IE00BFRSYJ83 +16.10% 17.07% 0.74
8. MEDICAL BioHealth EUR H LU0228344361 +23.93% 27.62% 0.74
9. J.Henderson Gl.Life Sciences F.I2 IE00BRJG6X20 +15.34% 15.79% 0.75
10. J.Henderson Gl.Life Sciences F.I2 H IE00BMXMTZ48 +15.36% 16.75% 0.71
...
294. Bellevue F.(L)-B.He.Strategy I CHF LU1477743030 -6.96% 14.63% -0.72